Systems assessment of intercalated combination of chemotherapy and EGFR TKIs versus chemotherapy or EGFR TKIs alone in advanced NSCLC patients

Both chemotherapy and epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) are widely applied for the treatment of non-small cell lung cancer (NSCLC), but the efficacy of these two treatments in combination is not yet clear. Thus, we sought to evaluate the efficacy of the intercal...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Han, Li, Qin, Wang, Wei, Zhen, Hongchao, Cao, Bangwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611484/
https://www.ncbi.nlm.nih.gov/pubmed/26481697
http://dx.doi.org/10.1038/srep15355

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611484/
https://www.ncbi.nlm.nih.gov/pubmed/26481697
http://dx.doi.org/10.1038/srep15355

Ejemplares similares